Antioxidant and renoprotective effects of paricalcitol on experimental contrast-induced nephropathy model

Author： ARI E KEDRAH A E ALAHDAB Y BULUT G EREN Z BAYTEKIN O ODABASI D

Publisher： British Institute of Radiology

ISSN： 0007-1285

Source： British Journal of Radiology, Vol.85, Iss.1016, 2012-08, pp. : 1038-1043

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence of Contrast-Induced Nephropathy with Volume Supplementation – Insights from a Large Cohort

Medical Principles and Practice, Vol. 17, Iss. 5, 2008-08 ,pp. : 409-414

Karger

Access to resources Recommend Favorite

Neutrophil Gelatinase–Associated Lipocalin as an Early Marker of Contrast‐Induced Nephropathy After Elective Invasive Cardiac Procedures

Clinical Cardiology, Vol. 39, Iss. 8, 2016-08 ,pp. : 464-470

John Wiley & Sons Inc

Access to resources Recommend Favorite

High‐volume forced diuresis with matched hydration using the RenalGuard System to prevent contrast‐induced nephropathy: A meta‐analysis of randomized trials

Clinical Cardiology, Vol. 40, Iss. 12, 2017-12 ,pp. : 1242-1246

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thrombogenic Potential of Contrast Media in an Experimental Model of Laser-Induced Thrombosis

By Aguejouf O. Malfatti E. Doutremepuich F. Doutremepuich C.

Thrombosis Research, Vol. 100, Iss. 3, 2000-11 ,pp. : 167-177

Elsevier

Access to resources Recommend Favorite

Effect of remote ischaemic conditioning on contrast-induced nephropathy in patients undergoing elective coronary angiography (ERICCIN): rationale and study design of a randomised single-centre, double-blind placebo-controlled trial

By Bell Robert Rear Roger Cunningham John Dawnay Anne Yellon Derek

Clinical Research in Cardiology, Vol. 103, Iss. 3, 2014-03 ,pp. : 203-209

Springer Publishing Company

Access to resources Recommend Favorite